“A Case Report on Therapeutic Optimization and Cardiometabolic Benefits of Semaglutide Therapy in Type 2 Diabetes Mellitus: Case Report” (2026) Journal of Pharma Insights and Research, 4(2), pp. 252–258. doi:10.69613/ss2yp015.